Stiff-person syndromes: Motor cortex hyperexcitability correlates with anti-GAD autoimmunity

Neurology

Volumn 62, Issue 8, 2004, Pages 1357-1362

  Koerner, Claudia ^a,b   Wieland, Bettina ^a   Richter, Wiltrud ^a   Meinck, Hans Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENCEPHALOMYELITIS; FEMALE; HUMAN; MALE; MOTOR CORTEX; MUSCLE RIGIDITY; NERVE EXCITABILITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; STIFF MAN SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 1942441680     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000120543.65812.33     Document Type: Article

References (39)

1. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasms ("stiff-man" syndrome): report of a case and some observations in 13 other cases. Mayo Clin Proc 1956;31:421-427.
2. Meinck HM, Ricker K, Hülser PJ, Schmid E, Peiffer J, Solimena M. Stiff man syndrome: clinical and laboratory findings in eight patients. J Neurol 1994;241:157-166.
3. Barker RA, Revesz T, Thom M, Marsden CD, Brown P. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry 1998;65:633-640.
4. Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord 2002;17:853-866.
5. Gordon EE, Januszko DM, Kaufmann L. A critical survey of stiff-man syndrome. Am J Med 1967;42:582-599.
6. Koerner C, Dinkel K, Richter W, Meinck HM. Intrathecal synthesis of glutamic acid decarboxylase in stiff man syndrome. Clin Neurophysiol 1999;110(suppl 1):S235. Abstract.
7. Dalakas MC, Li M, Fujii M, Jacobowitz DM. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD(65) antibodies. Neurology 2001;57:780-784.
8. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990;322:1555-1560.
9. Meinck HM, Faber L, Morgenthaler N, et al. Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J Neurol Neurosurg Psychiatry 2001;71:100-103.
10. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998;44:194-201.
11. Ishida K, Mitoma H, Song SY, et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 1999;46:263-267.
12. Meinck HM, Ricker K, Hülser PJ, Solimena M. Stiff man syndrome: neurophysiological findings in eight patients. J Neurol 1995;242:134-142.
13. Floeter MK, Valls-Sole J, Toro C, Jacobowitz D, Hallett M. Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology 1998;51:85-93.
14. Sandbrink F, Syed NA, Fujii MD, Dalakas MC, Floeter MK. Motor cortex excitability in stiff-person syndrome. Brain 2000;123:2231-2239.
15. Rothwell JC, Thompson PD, Day BL, Boyd S, Marsden CD. Stimulation of the human motor cortex through the scalp. Exp Physiol 1991;76:159-200.
16. Valls-Sole J, Pascual-Leone A, Wassermann EM, Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 1992;85:355-364.
17. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol (Lond) 1993;471:501-519.
18. Lorish TR, Thorssteinsson G, Howard FM Jr. Stiff-man syndrome updated [review]. Mayo Clin Proc 1989;64:629-636.
19. Richter W, Endl J, Eiermann TH, et al. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Proc Natl Acad Sci USA 1992;89:8467-8471.
20. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577.
21. Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology 1997;49:1292-1298.
22. Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol (Lond) 1996a;496:873-881.
23. Liepert J, Schwenkreis P, Tegenthoff M, Malin JP. The glutamate antagonist Riluzole suppresses intracortical facilitation. J Neural Transm 1997;104:1207-1214.
24. Ziemann U, Steinhoff BJ, Tergau F, Paulus W. Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 1998;30:11-30.
25. Matsumoto JY, Caviness JN, McEvoy KM. The acoustic startle reflex in stiff-man syndrome. Neurology 1994;44:1952-1955.
26. Ziemann U, Lönneker S, Paulus W. Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain 1995;118:1437-1446.
27. Inghilleri M, Berardelli A, Marchetti P, Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 1996;109:467-472.
28. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996b; 109:127-135.
29. Mavroudakis N, Caroyer JM, Brunko E, Zegers de Beyl D. Effects of vigabatrin on motor potentials with magnetic stimulation. Electroencephalogr Clin Neurophysiol 1997;105:124-127.
30. Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 1991;81:257-262.
31. Inghilleri M, Berardelli A, Cruccu G, Manfredi M. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol (Lond) 1993;466:521-534.
32. Ziemann U, Netz J, Szelenyi A, Hömberg V. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex. Neurosci Lett 1993;156:167-171.
33. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996c;40:367-378.
34. Martinelli P, Pazzaglia P, Montagna P, et al. Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J Neurol Neurosurg Psychiatry 1978;41:458-462.
35. Peltola J, Kulmala P, Isojärvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000;55:46-50.
36. Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 2000;42:191-195.
37. Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 2002;23:145-151.
38. Kash SF, Johnson RS, Tecott LH, et al. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 1997;94:14060-14065.
39. During MJ, Symes CW, Lawlor PA, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000;287:1453-1459.